IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Juno Therapeutics Inc

CUSIP: 48205A909 | 8 institutional holders

Quarters

Q4 2017Q3 2017Q2 2017Q1 2017Q4 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile